BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 16187023)

  • 1. Cyclin D1 genotype and expression in sporadic hemangioblastomas.
    Gijtenbeek JM; Boots-Sprenger SH; Franke B; Wesseling P; Jeuken JW
    J Neurooncol; 2005 Sep; 74(3):261-6. PubMed ID: 16187023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of cyclin D1 and other novel targets for the von Hippel-Lindau tumor suppressor gene by expression array analysis and investigation of cyclin D1 genotype as a modifier in von Hippel-Lindau disease.
    Zatyka M; da Silva NF; Clifford SC; Morris MR; Wiesener MS; Eckardt KU; Houlston RS; Richards FM; Latif F; Maher ER
    Cancer Res; 2002 Jul; 62(13):3803-11. PubMed ID: 12097293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular genetic analysis of the von Hippel-Lindau disease tumor suppressor gene in familial and sporadic cerebellar hemangioblastomas.
    Tse JY; Wong JH; Lo KW; Poon WS; Huang DP; Ng HK
    Am J Clin Pathol; 1997 Apr; 107(4):459-66. PubMed ID: 9124215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatic mutations of the von Hippel-Lindau tumor suppressor gene in sporadic central nervous system hemangioblastomas.
    Kanno H; Kondo K; Ito S; Yamamoto I; Fujii S; Torigoe S; Sakai N; Hosaka M; Shuin T; Yao M
    Cancer Res; 1994 Sep; 54(18):4845-7. PubMed ID: 8069849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurosurgical treatment of von Hippel-Lindau-associated hemangioblastomas: benefits, risks and outcome.
    Pavesi G; Feletti A; Berlucchi S; Opocher G; Martella M; Murgia A; Scienza R
    J Neurosurg Sci; 2008 Jun; 52(2):29-36. PubMed ID: 18500215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A vitronectin M381T polymorphism increases risk of hemangioblastoma in patients with VHL gene defect.
    Huang JS; Lin CM; Cheng YC; Hung KL; Chien CC; Chen SK; Chang CJ; Chen CW; Huang CJ
    J Mol Med (Berl); 2009 Jun; 87(6):613-22. PubMed ID: 19288063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Von Hippel-Lindau disease germline mutations in Mexican patients with cerebellar hemangioblastoma.
    Rasmussen A; Nava-Salazar S; Yescas P; Alonso E; Revuelta R; Ortiz I; Canizales-Quinteros S; Tusié-Luna MT; López-López M
    J Neurosurg; 2006 Mar; 104(3):389-94. PubMed ID: 16572651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of von hippel-lindau mutations with comparative genomic hybridization in sporadic and hereditary hemangioblastomas: possible genetic heterogeneity.
    Gijtenbeek JM; Jacobs B; Sprenger SH; Eleveld MJ; van Kessel AG; Kros JM; Sciot R; van Calenbergh F; Wesseling P; Jeuken JW
    J Neurosurg; 2002 Oct; 97(4):977-82. PubMed ID: 12405390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of heterozygosity at 6q is frequent and concurrent with 3p loss in sporadic and familial capillary hemangioblastomas.
    Lemeta S; Pylkkänen L; Sainio M; Niemelä M; Saarikoski S; Husgafvel-Pursiainen K; Böhling T
    J Neuropathol Exp Neurol; 2004 Oct; 63(10):1072-9. PubMed ID: 15535134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The natural history of hemangioblastomas of the central nervous system in patients with von Hippel-Lindau disease.
    Wanebo JE; Lonser RR; Glenn GM; Oldfield EH
    J Neurosurg; 2003 Jan; 98(1):82-94. PubMed ID: 12546356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Von Hippel-Lindau disease: recent genetic progress and patient management. Francophone Study Group of von Hippel-Lindau Disease (GEFVH)].
    Richard S; Giraud S; Beroud C; Caron J; Penfornis F; Baudin E; Niccoli-Sire P; Murat A; Schlumberger M; Plouin PF; Conte-Devolx B
    Ann Endocrinol (Paris); 1998; 59(6):452-8. PubMed ID: 10189987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Difference in CXCR4 expression between sporadic and VHL-related hemangioblastoma.
    Kruizinga RC; van Marion DM; den Dunnen WF; de Groot JC; Hoving EW; Oosting SF; Timmer-Bosscha H; Derks RP; Cornelissen C; van der Luijt RB; Links TP; de Vries EG; Walenkamp AM
    Fam Cancer; 2016 Oct; 15(4):607-16. PubMed ID: 26920352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of cyclin D1 (CCND1) allelic imbalance and overexpression in sporadic human pituitary tumors.
    Hibberts NA; Simpson DJ; Bicknell JE; Broome JC; Hoban PR; Clayton RN; Farrell WE
    Clin Cancer Res; 1999 Aug; 5(8):2133-9. PubMed ID: 10473097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological study of vascular endothelial growth factor (VEGF), p53, and proliferative potential in familial von Hippel-Lindau disease and sporadic hemangioblastomas.
    Miyagami M; Katayama Y; Nakamura S
    Brain Tumor Pathol; 2000; 17(3):111-20. PubMed ID: 11310918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclin D1 protein expression and gene polymorphism in colorectal cancer. Aberdeen Colorectal Initiative.
    McKay JA; Douglas JJ; Ross VG; Curran S; Murray GI; Cassidy J; McLeod HL
    Int J Cancer; 2000 Oct; 88(1):77-81. PubMed ID: 10964085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and molecular analysis of disseminated hemangioblastomatosis of the central nervous system in patients without von Hippel-Lindau disease. Report of four cases.
    Weil RJ; Vortmeyer AO; Zhuang Z; Pack SD; Theodore N; Erickson RK; Oldfield EH
    J Neurosurg; 2002 Apr; 96(4):775-87. PubMed ID: 11990821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Does hemangioblastoma exist outside von Hippel-Lindau disease?].
    Richard S; Beigelman C; Gerber S; Van Effenterre R; Gaudric A; Sahel M; Binaghi M; De Kersaint-Gilly A; Houtteville JP; Brunon JP
    Neurochirurgie; 1994; 40(3):145-54. PubMed ID: 7723921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclin D1 gene (CCND1) polymorphism and the risk of squamous cell carcinoma of the larynx.
    Rydzanicz M; Golusinski P; Mielcarek-Kuchta D; Golusinski W; Szyfter K
    Eur Arch Otorhinolaryngol; 2006 Jan; 263(1):43-8. PubMed ID: 16258756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of heterozygosity and somatic mutations of the VHL tumor suppressor gene in sporadic cerebellar hemangioblastomas.
    Lee JY; Dong SM; Park WS; Yoo NJ; Kim CS; Jang JJ; Chi JG; Zbar B; Lubensky IA; Linehan WM; Vortmeyer AO; Zhuang Z
    Cancer Res; 1998 Feb; 58(3):504-8. PubMed ID: 9458097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Von Hippel-Lindau disease and central nervous system hemangioblastoma. Progress in genetics and clinical management].
    Richard S; Martin S; David P; Decq P
    Neurochirurgie; 1998 Nov; 44(4):258-66. PubMed ID: 9864697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.